2.5. NMR and MS Data of the Identified Compounds
Stearic acid (1): 1H NMR (600 MHz, CDCl3) δ: 2.31 (2H, t, J = 7.5 Hz, H-2), 1.62 (2H, m, H-3), 1.27 (28H, m, -(CH2)n-), 0.88 (3H, t, J = 6.9 Hz, Me-18). ESI-MS: m/z 307.5 [M+Na]+.
Oleic acid (2): 1H NMR (600 MHz, CDCl3) δ: 5.37 (2H, m, H-9 and H-10), 2.31 (2H, t, J = 7.5 Hz, H-2), 2.03 (4H, m, H-8 and H-11), 1.62 (2H, m, H-3), 1.27 (20H, m, -(CH2)n-), 0.88 (3H, t, J = 6.9 Hz, Me-18). ESI-MS: m/z 305.4 [M+Na]+.
Linoleic acid (3): 1H NMR (600 MHz, CDCl3) δ: 5.37 (4H, m, H-9 and H-10 and H-12 and H-13), 2.76 (2H, m, H-11), 2.31 (2H, t, J = 7.5 Hz, H-2), 2.03 (4H, m, H-8 and H-14), 1.62 (2H, m, H-3), 1.27 (14H, m, -(CH2)n-), 0.96 (3H, t, J = 6.9 Hz, Me-18). ESI-MS: m/z 303.5 [M+Na]+.
Linolenic acid (4): 1H NMR (600 MHz, CDCl3) δ: 5.37 (6H, m, H-9 and H-10 and H-12 and H-13 and H-15 and H-16), 2.78 (4H, m, H-11 and H-14), 2.31 (2H, t, J = 7.5 Hz, H-2), 2.03 (4H, m, H-8 and H-17), 1.62 (2H, m, H-3), 1.27 (8H, m, -(CH2)n-), 0.89 (3H, t, J = 6.9 Hz, Me-18). ESI-MS: m/z 301.3 [M+Na]+.
Β-sitosterol (5): 1H NMR (600 MHz, CDCl3) δ: 5.36-5.33 (1H, m, H-6), 3.56-3.53 (1H, m, H-3), 2.35-2.31 (2H, m, H-4), 2.01-1.96 (1H, m, Ha-7), 1.88-1.82 (3H, overlapped, Ha-1, Ha-2, Ha-16), 1.60-1.57 (2H, m, H-15), 1.54-1.45 (3H, overlapped, Hb-2, Hb-7, H-8), 1.26-1.23 (1H, m, Hb-16), 1.10-1.06 (1H, m, Hb-1), 1.02 (3H, s, Me-19), 1.00-0.98 (1H, m, H-14), 0.68 (3H, s, Me-18). ESI-MS: m/z 437.4 [M+Na]+.
15-agathic acid methyl ester (6): 1H NMR (600 MHz, CDCl3) δ: 5.63 (1H, d, J = 1.0 Hz, H-14), 4.86 (1H, br. s, H-17a), 4.51 (1H, br. s, H-17b), 3.67 (3H, s, COOMe), 2.14 (3H, s, Me-16), 1.12 (3H, s, Me-19), 0.73 (3H, s, Me-20). ESI-MS: m/z 371.5 [M+Na]+.
Methyl (E)-communate (7): 1H-NMR (600 MHz, CDCl3) δ: 6.31 (1H, dd, J = 17.8, 10.8, H-14), 5.37-5.34 (1H, overlapped, H-12), 5.31-5.27 (1H, overlapped, Ha-15), 5.08 (1H, br. s, Ha-17), 4.88 – 4.85 (1H, overlapped, Hb-15), 4.48 (1H, br. s, Hb-17), 3.46 (3H, s, 18-OMe), 1.67 (3H, s, Me-16), 1.25 (3H, s, Me-19), 0.67 (3H, s, Me-20). ESI-MS: m/z 339.4 [M+Na]+.
Shikimic acid (8): 1H-NMR (600 MHz, D2O) δ: 6.48-6.43 (1H, m, H-2), 4.31 (1H, t, J = 3.8 Hz, H-3), 4.31 (1H, t, J = 3.8 Hz, H-3), 3.91-3.87 (1H, m, H-5), 3.68-3.64 (1H, m, H-4), 2.60 (1H, dd, J = 18.3, 6.9 Hz, Ha-6), 2.10 (1H, dd, J = 18.3, 7.3 Hz, Hb-6). ESI-MS: m/z 197.3 [M+Na]+; m/z 173.2 [M-H]-.
Gallic acid (9): 1H-NMR (600 MHz, D2O) δ: 7.04 (2H, s, H-2 and H-6). ESI-MS: m/z 169.1 [M-H]-.
P-hydroxy-benzoic acid (10): 1H-NMR (600 MHz, D2O) δ: 7.75 (2H, d, J = 8.0 Hz, H-2 and H-6), 6.95 (2H, d, J = 8.0 Hz, H-3 and H-5). ESI-MS: m/z 161.2 [M+Na]+; m/z 137.0 [M-H]-.
Fumaric acid (11): 1H-NMR (600 MHz, D2O) δ: 6.51 (2H, s, H-α and H-β). ESI-MS: m/z 115.2 [M-H]-.
Succinic acid (12): 1H-NMR (600 MHz, D2O) δ: 2.38 (4H, s, H-α and H-β). ESI-MS: m/z 117.0 [M-H]-.
Quinic acid (13): 1H-NMR (600 MHz, D2O) δ: 4.14-4.10 (1H, m, H-4), 3.99-3.94 (1H, m, H-5), 3.57-3.53 (1H, m, H-3), 2.12-2.08 (4H, overlapped, Ha-2, Hb-2, Ha-6, Hb-6). ESI-MS: m/z 191.1 [M-H]-.
Butyric acid (14): 1H-NMR (600 MHz, D2O) δ: 2.27 (2H, t, J = 7.3 Hz, H-α), 1.38 (2H, m, H-β), 0.90 (3H, t, J = 7.4 Hz, H-γ). ESI-MS: m/z 87.2 [M-H]-.
Iso-butyric acid (15): 1H-NMR (600 MHz, D2O) δ: 2.40-2.37 (1H, m, H-α), 0.92 (6H, d, J = 7.0 Hz, H-β and H-β'). ESI-MS: m/z 87.2 [M-H]-.
Formic acid (16): 1H-NMR (600 MHz, D2O): 8.45 (1H, s, CH). ESI-MS: m/z 45.2 [M-H]-.
Acetic acid (17): 1H-NMR (600 MHz, D2O) δ: 1.92 (3H, s, Me). ESI-MS: m/z 59.1 [M-H]-.
Citric acid (18): 1H-NMR (600 MHz, D2O) δ: 2.71 (2H, d, J = 14.9 Hz, Ha-α and Ha-γ), 2.67 (2H, d, J = 14.9 Hz, Hb-α and Hb-γ). ESI-MS: m/z 191.1 [M-H]-.
Iso-valeric acid (19): 1H-NMR (600 MHz, D2O) δ: 2.15-2.05 (2H, m, H-α), 1.97-1.93 (1H, m, H-β), 0.91 (6H, d, J = 6.6 Hz, Me-γ and Me-γ'). ESI-MS: m/z 101.3 [M-H]-.
Lactic acid (20): 1H-NMR (600 MHz, D2O) δ: 4.11 (1H, q, J = 8.1 Hz, H-α), 1.31 (3H, d, J = 8.1 Hz, Me). ESI-MS: m/z 89.0 [M-H]-.
Myo-inositol (21): (600 MHz, D2O) δ: 4.07 (1H, t, J = 2.8 Hz, H-1), 3.64 (2H, m, H-4 and H-6), 3. 53 (2H, m, H-2 and H-3), 3.28 (1H, m, H-5). ESI-MS: m/z 202.7 [M+Na]+; m/z 179.1 [M-H]-.
A-glucose (22): 1H-NMR (600 MHz, D2O) δ: 5.22 (1H, d, J = 3.7 Hz, H-1), 3.87-3.84 (1H, m, H-5), 3.80-3.74 (2H, m, H-6), 3.75-3.72 (1H, m, H-3), 3.59-3.54 (1H, m, H-2), 3.47-3.41 (1H, m, H-4). ESI-MS: m/z 202.7 [M+Na]+; m/z 179.1 [M-H]-.
B-glucose (23): 1H-NMR (600 MHz, D2O) δ: 4.65 (1H, d, J = 8.0 Hz, H-1), 3.91-3.89 (1H, m, Ha-6), 3.79-3.75 (1H, m, Hb-6), 3.53-3.50 (1H, m, H-3), 3.49-3.46 (1H, m, H-5), 3.44-3.40 (1H, m, H-4), 3.29-3.25 (1H, m, H-2). ESI-MS: m/z 202.7 [M+Na]+; m/z 179.1 [M-H]-.
A-galactose (24): 1H-NMR (600 MHz, D2O) δ: 5.26 (1H, d, J = 3.7 Hz, H-1), 4.10-4.07 (1H, m, H-5), 4.00-3.97 (1H, m, H-3), 3.79-3.75 (2H, m, H-2 and H-4), 3.73-3.70 (2H, m, H-6). ESI-MS: m/z 202.7 [M+Na]+; m/z 179.1 [M-H]-.
B-galactose (25): 1H-NMR (600 MHz, D2O) δ: 4.59 (1H, d, J = 8.0 Hz, H-1), 3.99-3.96 (1H, m, H-4), 3.84-3.81 (2H, m, H-6), 3.74-3.71 (1H, m, H-5), 3.64-3.61 (1H, m, H-3), 3.51-3.48 (1H, m, H-2). ESI-MS: m/z 202.7 [M+Na]+; m/z 179.1 [M-H]-.
A-xylose (26): 1H-NMR (600 MHz, D2O) δ: 5.20 (1H, d, J = 3.7 Hz, H-1), 3.73-3.69 (1H, m, H-3), 3.65-3.62 (1H, m, H-4), 3.48-3.43 (2H, m, H-5), 3.37-3.34 (1H, m, H-2). ESI-MS: m/z 173.2 [M+Na]+; m/z 149.1 [M-H]-.
B-xylose (27): 1H-NMR (600 MHz, D2O) δ: 4.56 (1H, d, J = 7.9 Hz, H-1), 3.89-3.86 (2H, m, H-5), 3.71-3.68 (1H, m, H-3), 3.38-3.35 (1H, m, H-4), 3.19-3.16 (1H, m, H-2). ESI-MS: m/z 173.2 [M+Na]+; m/z 149.1 [M-H]-.
Fructose (28): 1H-NMR (600 MHz, D2O) δ: 4.15 (1H, d, J = 8.8 Hz, H-3), 4.04-4.01 (1H, m, H-4), 3.82 (2H, s, H-6), 3.71 (2H, s, H-1). ESI-MS: m/z 202.7 [M+Na]+; m/z 179.1 [M-H]-.
Sucrose (29): 1H-NMR (600 MHz, D2O) δ: 5.40 (1H, d, J = 3.9 Hz, H-1), 4.20 (1H, d, J = 8.8 Hz, H-3'), 4.07-4.03 (1H, m, H-4'), 3.90-3.84 (3H, m, H-5 and H-6), 3.80 (2H, s, H-6'), 3.77-3.74 (1H, m, H-3), 3.70 (2H, s, H-1'), 3.58-3.53 (1H, m, H-2), 3.49-3.45 (1H, m, H-4). ESI-MS: m/z 365.5 [M+Na]+; m/z 341.3 [M-H]-.
Alanine (30): 1H-NMR (600 MHz, D2O) δ: 3.80 (1H, q, J = 7.1 Hz, H-α), 1.49 (3H, d, J = 7.1 Hz, Me). ESI-MS: m/z 88.1 [M-H]-.
Arginine (31): 1H-NMR (600 MHz, D2O) δ: 3.77-3.74 (1H, m, H-α), 3.25 (2H, t, J = 8.9 Hz, H-δ), 1.94-1.91 (2H, m, H-β), 1.71-1.68 (2H, m, H-γ). ESI-MS: m/z 173.2 [M-H]-.
Glutamic acid (32): 1H-NMR (600 MHz, D2O) δ: 3.76-3.73 (1H, m, H-α), 2.37-2.32 (2H, m, H-β), 2.11-2.08 (2H, m, H-γ). ESI-MS: m/z 146.0 [M-H]-.
Iso-leucine (33): 1H-NMR (600 MHz, D2O) δ: 3.88-3.85 (1H, m, H-α), 2.00-1.97 (1H, m, H-β), 1.42-1.25 (2H, m, H-γ), 1.02 (3H, d, J = 7.0 Hz, Me-γ'), 0.95 (3H, t, J = 7.4 Hz, Me-δ). ESI-MS: m/z 130.2 [M-H]-.
Leucine (34): 1H-NMR (600 MHz, D2O) δ: 3.77-3.72 (1H, m, H-α), 1.74-1.70 (3H, m, H-β and H-γ), 0.99-0.95 (6H, m, H-δ and H-δ'). ESI-MS: m/z 130.2 [M-H]-.
Lysine (35): 1H-NMR (600 MHz, D2O) δ: 3.81-3.76 (1H, m, H-α), 3.03 (2H, t, J = 8.2 Hz, H-δ), 1.98-1.93 (2H, m, H-β), 1.70-1.67 (2H, m, H-γ), 1.49-1.45 (2H, m, H-δ). ESI-MS: m/z 145.1 [M-H]-.
Phenyl-alanine (36): 1H-NMR (600 MHz, D2O) δ: 7.43-7.40 (2H, m, H-3 and H-5), 7.39-7.36 (1H, m, H-4), 7.34-7.30 (2H, m, H-2 and H-6), 3.99-3.96 (1H, m, H-α), 3.28-3.25 (2H, m, H-β). ESI-MS: m/z 164.2 [M-H]-.
Threonine (37): 1H-NMR (600 MHz, D2O) δ: 4.26-4.23 (1H, m, H-β), 3.82-3.78 (1H, m, H-α), 1.32 (3H, d, J = 6.6 Hz, Me). ESI-MS: m/z 118.1 [M-H]-.
Tryptophan (38): 1H-NMR (600 MHz, D2O) δ: 7.74-7.71 (1H, m, H-4), 7.28-7.25 (1H, m, H-6), 7.21-7.18 (1H, m, H-5), 4.08-4.03 (1H, m, H-α), 3.31-3.29 (2H, m, H-β). ESI-MS: m/z 203.2 [M-H]-.
Tyrosine (39): 1H-NMR (600 MHz, D2O) δ: 7.20 (2H, d, J = 8.8 Hz, H-2 and H-6), 6.89 (2H, d, J = 8.8 Hz, H-3 and H-5), 3.95-3.91 (1H, m, H-α), 3.18-3.14 (2H, m, H-β). ESI-MS: m/z 180.3 [M-H]-.
Valine (40): 1H-NMR (600 MHz, D2O) δ: 3.64-3.60 (1H, m, H-α), 2.31-2.28 (1H, m, H-β), 1.05 (3H, d, J = 7.1 Hz, Me-γ'), 0.99 (3H, d, J = 7.0 Hz, Me-γ). ESI-MS: m/z 116.1 [M-H]-.